Munchen, Germany
ADVITOS GmbH, founded in 2005 and headquartered in Germany, is a promising player in the Health and Wellness and Medical Devices industries. The company innovatively combines multiorgan support into a single device with its CE-certified, globally patented ADVOS - ADVanced Organ Support therapy. This groundbreaking solution enhances patient survival rates by supporting the liver, lung, and kidneys simultaneously.
The ADVOS therapy stands out by its capability to remove water-soluble toxins, protein-bound toxins, and CO2 and manage the blood pH levels. Its adoption in 20 leading university clinics across Germany underscores its clinical impact, and the company's expansion efforts are set to reach international markets.
ADVITOS secured a significant €20M investment in a Venture Round on 10 June 2021 from top-tier investors such as Crédit Mutuel Innovation and the European Innovation Council. Notably, the company is supported by the Horizon 2020 initiative of the European Union, indicating strong backing and growth prospects.
